NCT00413426View on ClinicalTrials.gov

Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

September 30, 2007

Conditions
Healthy
Interventions
DRUG

Darifenacin (DAR328)

Trial Locations (1)

Unknown

Novartis Investigative Site, Mumbai

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Novartis

INDUSTRY